Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia

Cancer Cell - United States
doi 10.1016/j.ccell.2018.07.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

SET-NUP214 Fusion in Acute Myeloid Leukemia- And T-Cell Acute Lymphoblastic Leukemia-Derived Cell Lines

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2009English

A NOTCH1-driven MYC Enhancer Promotes T Cell Development, Transformation and Acute Lymphoblastic Leukemia

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

The Variant Translocation of ABL1 Gene T(2;9)(q21;q34) in a Childhood T-Cell Acute Lymphoblastic Leukemia

Bratislava Medical Journal
2012English

Pre-T Cell Receptor Signaling Drives Leukemogenesis and Is a Therapeutic Target in T Cell Acute Lymphoblastic Leukemia

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

STAT5 Activation in B-Cell Acute Lymphoblastic Leukemia: Damned if You Do, Damned if You Don't

Cancer Cell & Microenvironment
2016English

A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

OncoTargets and Therapy
OncologyPharmacology
2018English

Γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients

Clinical Cancer Research
Cancer ResearchOncology
2011English

Targeting IRAK1 in T-Cell Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy